LIVE TV
ZEE Business
ZEE BUSINESS
हिंदी में पढ़ें  हिंदी में पढ़ें
Live TV
Live TV
  • Home
  • Budget 2021
  • Personal Finance
    • PPF
    • Mutual Funds
    • Income tax
    • EPFO
    • Income Tax Calculator
    • Personal Loan Calculator
    • Car Loan Calculator
    • Home Loan Calculator
    • SIP calculator
    • SWP Calculator
    • MF Returns Calculator
    • Lumpsum Calculator
  • India
    • Companies
    • Property
    • Startups
    • Uidai
  • Economy
    • Aviation
  • Tech
    • Mobiles
    • Apps
  • Auto
    • Cars
    • Bikes
  • Markets
    • Commodities
    • Currency
  • Jobs
  • Indian Railways
  • World
    • Economy
    • Politics
    • Markets
  • videos
  • photos
  • Authors
  • More ...
    • VIDEOS
    • PHOTOS

Read in App
Business News » World News

Drugmaker Teva hires Lundbeck CEO Schultz to restore its health

  • Twitter
  • Facebook
  • Linkedin
  • whatapp
  • View in App
Updated: Mon, Sep 11, 2017
04:23 pm
Reuters
RELATED NEWS
Expert Views: BIG! India's retail inflation eases to 4.59% in December Expert Views: BIG! India's retail inflation eases to 4.59% in December
Budget 2021 Expectations – HOME BUYERS to benefit if Govt accepts this demand; JLL CEO lists following demands Budget 2021 Expectations – HOME BUYERS to benefit if Govt accepts this demand; JLL CEO lists following demands
Jobs, land prices, Covid-19 vaccine, rural India, household savings, NBFCs, banks, consumption, capex - Positives and Negatives | EXPLAINED Jobs, land prices, Covid-19 vaccine, rural India, household savings, NBFCs, banks, consumption, capex - Positives and Negatives | EXPLAINED
Economy, markets, FIIs, chemicals, IT and Pharma - Make money, as India powers to new highs | EXPLAINED    Economy, markets, FIIs, chemicals, IT and Pharma - Make money, as India powers to new highs | EXPLAINED
Setback for China – Trend reversing in favour of India; SFI lands big blow! Know here WHY! Setback for China – Trend reversing in favour of India; SFI lands big blow! Know here WHY!

Teva poached Lundbeck`s Kare Schultz as its new chief executive on Monday, handing the drugs industry veteran the urgent task of convincing investors of the struggling Israeli firm`s future.

A costly acquisition spree in recent years has saddled Teva with huge debts and eroded shareholder confidence in the generic drugs maker, whose stock has dropped by 50 percent since early August when it cut both its forecasts and its dividend.

The first task for Schultz, named CEO after a seven-month search, will be to decide whether to maintain Teva as both a generics and specialty drugmaker, split it in two or get out of low-margin, high competition generics altogether.

Schultz said he will develop a joint strategy with the board and management that would address the "various restructuring initiatives" as well as Teva`s more than $35 billion in debt.

Teva -- the world`s largest generics drugmaker -- is selling off non-core businesses such as its women`s health business and European oncology and pain unit to cut its debts.

"There will be a very clear strategy that will be communicated once we`re ready to do that," he told Reuters.

Teva`s shareholders welcomed the 56-year-old`s appointment, with its Tel Aviv-listed shares rising by 13 percent.

But shares in Denmark`s Lundbeck fell by over 12 percent as investors digested the departure of both Schultz and Staffan Schueberg, its chief commercial officer, who has also quit.

Teva, which cooperates with Lundbeck on a number of drugs, said no start date has been set for Schultz, adding he will join the company and relocate to Israel as soon as practicable.

The Israel-based company is facing accelerating price erosion in the United States and working out how to reduce the debts it took on to finance the $40.5 billion purchase of Allergan`s generics business last year.

Analysts and investors said Teva paid too much for Actavis and that led to the departure in February of CEO Erez Vigodman.

"We need to restore credibility," Teva Chairman Sol Barer told Reuters. "It`s early but ... he (Schultz) will dive in and come up rapidly with a strategic plan."

Barer said Teva had "no plans now" to split in two.SIGNIFICANT CREDIBILITY

Barer and Teva`s board have been criticized for taking so long to hire a new CEO.

"We wanted to make sure we got it right," Barer said, noting that Schultz hit all of the board`s criteria, including global and pharmaceutical experience.

"Critically, he has successful turnaround experience. At Lundbeck, it was a troubled company and he turned it around and created significant value for shareholders. And, he has significant credibility with stakeholders," Barer said.

Schultz will succeed Yitzhak Peterburg, who will continue as Teva`s interim CEO until Schultz takes over.

Schultz had been widely seen as heir apparent at the world`s largest diabetes drugmaker Novo Nordisk but quit in 2015 when Novo`s former CEO said he would stay until 2019.

He became CEO of Lundbeck in May 2015 shortly and the Danish firm`s share price has more than tripled since he took over and returned it to profit by slimming costs.

At Teva, Schultz will also face significant challenges.

The company has put Iceland-based Medis, a supplier of development work to third-party drugmakers, up for sale and is looking to team up with other drugmakers to fund some of its development pipeline.

Its problems also stem in large part from its specialty business. Its blockbuster multiple sclerosis drug Copaxone had contributed much of Teva`s revenue and profit, but its patent has run out and now is facing generic competition.

(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

TAGS:
Economy
RELATED NEWS
Expert Views: BIG! India's retail inflation eases to 4.59% in December Expert Views: BIG! India's retail inflation eases to 4.59% in December
Budget 2021 Expectations – HOME BUYERS to benefit if Govt accepts this demand; JLL CEO lists following demands Budget 2021 Expectations – HOME BUYERS to benefit if Govt accepts this demand; JLL CEO lists following demands
Jobs, land prices, Covid-19 vaccine, rural India, household savings, NBFCs, banks, consumption, capex - Positives and Negatives | EXPLAINED Jobs, land prices, Covid-19 vaccine, rural India, household savings, NBFCs, banks, consumption, capex - Positives and Negatives | EXPLAINED
Economy, markets, FIIs, chemicals, IT and Pharma - Make money, as India powers to new highs | EXPLAINED    Economy, markets, FIIs, chemicals, IT and Pharma - Make money, as India powers to new highs | EXPLAINED
Setback for China – Trend reversing in favour of India; SFI lands big blow! Know here WHY! Setback for China – Trend reversing in favour of India; SFI lands big blow! Know here WHY!

LATEST NEWS

In exclusive chat with Anil Singhvi, Borosil MD and CEO Shreevar Kheruka talks about business outlook, Budget 2021 expectations, expansion plans and much more

Earthquake Today: Massive magnitude 7.0 quake shakes Philippines; US Geological Survey says no tsunami warning require

Budget 2021: Stock markets to continue their rally ahead with minor hiccups

CBSE Class 10, Class 12 exams 2021: Datasheet announcement, fake news, syllabus and other latest updates students must know

7th Pay Commission Latest News Today 2021: Big 7th CPC announcement for central government employees; Modi government unveils this

Sensex crashes 746 pts as profit-taking deepens; posts weekly loss

Asian paints share price: Sharekhan revises price target to Rs 3000 after Q3 results

Budget 2021: What IT wants from FM Nirmala Sitharaman - a Cyber Security Policy like Income Tax, GST

Important notification from HDFC Securities! Can't place any order from this date; will be back after gap on January 25

Airtel Rs 78, Rs 248 PrePaid Plans Offer: Add-on packs with Wynk Premium subscription launched | Check FULL details here

  • India News
  • World News
  • Companies News
  • Market News
  • Personal Finance News
  • Technology News
  • Automobile News
  • Small Business News
  • Income Tax Calculator
  • Live TV
  • Videos
  • Photos
  • Author
  • Rss Feed
  • Advertise with us
  • Privacy Policy
  • Legal Disclaimer

Latest Trending Updates

  • EPFO
  • Budget 2020
  • Income Tax Return
  • Auto Expo 2020
  • Home Loan
  • Business News

Trending Topics

  • Income Tax
  • income Tax Calculator
  • 7th Pay Commission
  • Reserve Bank of India
  • GST
  • Latest Business News

Follow us on

zeebiz
zeebiz

Partner Sites

  • Zee News
  • Hindi News
  • Marathi News
  • Bengali News
  • Tamil News
  • Malayalam News
  • Gujarati News
  • Telugu News
  • Kannada News
  • DNA
  • WION
Copyright © Zee Media Corporation Ltd. All rights reserved